News, stories and opinions for the business innovators of the world.

Medical Design Excellence Awards (MDEAs) in New York recognize Planet Innovation with two Gold Awards

Roger LangsdonMarketing Director

Planet Innovation was a standout performer picking up two of the highest honors at this year’s MDEAs for innovation in medical product design and engineering.

Planet Innovation and its partner, Genea Biomedx, picked up MDEA Gold Awards for Genea’s Gavi and Geri medical instruments.

Gavi is the world’s first instrument to automate IVF vitrification, the process of freezing embryos for use in later cycles. By automating and standardizing the process, historically a manual process subject to variability, Gavi aims to improve patient outcomes and the likelihood of patients taking home a healthy baby.

Geri is the world’s first incubator that combines a low-cost imaging system within each individually controlled patient incubator chamber. Embryologists can assess embryo development without taking the embryo out of its optimal environment. High-quality time-lapse images are taken while the embryo remains safe within Geri.

The winners are chosen by an impartial panel of judges comprised of clinicians, engineers and designers with years of experience in the industry. Judgement is based on five criteria, including design and engineering innovations, functional innovations, benefits to overall healthcare, benefits to patients, and competitive landscape.

Troy O’Callaghan, Executive Director at Planet Innovation, received the award on behalf of Planet Innovation and Genea Biomedx: “Planet Innovation works with clients all around the world and we pride ourselves on helping our clients think differently about every new product opportunity. That thinking starts right at the beginning when we are first exploring the gap in the market, and sculpting our client’s product roadmap. It’s about finding market insights that others may have missed and exploiting those gaps to launch a product that truly dominates a market. Planet Innovation has a strong product-market fit capability that talks to real customers and ensures the product design is optimized for the true needs of the industry.”

SHARE THIS ARTICLE:
Roger Langsdon Marketing Director
Roger Langsdon

Roger is the Marketing Director at Planet Innovation and a specialist marketing and communications professional with a focus on growing an organization’s reputation and revenue through strategic marketing and high-impact communications.

Roger Langsdon

Related Articles.

Genea CEO: From idea to Product of the Year

Product Dev

Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.

The secret behind the consumable ‘pod’ that pioneered IVF automation

Product Dev

PI Executive Director Eduardo Vom reveals the details to the microfluidic pod that was developed for the Gavi instrument to enable automated IVF vitrification for the first time in the world.

Genea’s IVF deal with Merck secures manufacturing contract for PI

News

Pharmaceutical giant Merck Serono has signed an exclusive deal securing global marketing and commercialization rights to Genea Biomedx’s range of IVF products including Gavi and Geri, which were designed by Genea with development partner, Planet Innovation.

APAS Independence wins global accolades at Medical Design Excellence Awards

Diagnostics

Clever Culture Systems has collected silver at the prestigious Medical Design Excellence Awards (MDEAs) for its innovative APAS Independence instrument, which Planet Innovation helped develop.

Product Dev

Genea CEO: From idea to Product of the Year

Tomas Stojanov has been an integral part of an extremely successful network of invitro-fertilisation (IVF) clinics in his role as the CEO of fertility group Genea, but his personal dream is to do more. He wanted to change the world of IVF to benefit his company, his industry and most importantly his patients.